Pharmaceutical Technology\'s In the Lab eNewsletter-01-09-2019

January 09, 2019

Unprocessed bulk material harvested directly from the bioreactor should be tested for contamination prior to downstream processing.

January 09, 2019

Fluorescence has long been used to detect biological targets. As these measurements are becoming more and more quantitative, standards are needed to ensure accuracy and reproducibility.

January 07, 2019

The companies entered a license agreement for the Trianni Mouse, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies (mAbs), to support MacroGenics’ discovery programs for mAb-based therapeutics.

January 07, 2019

A new plasma B cell antibody discovery workflow launched by Berkeley Lights enables the shortening of antibody drug discovery from month to a day.

January 07, 2019

The new reagents are designed to support clinical-phase and commercialization stages of cell and gene therapy production and to enhance DNA transfection.

January 07, 2019

The Steritest NEO device from MilliporeSigma provides safer pharmaceutical product testing through additional features.

December 14, 2018

Eli Lilly and AC Immune have signed a license and collaboration agreement focussing on the R&D of tau aggregation inhibitor small molecules for the potential treatment of neurodegenerative diseases.

December 14, 2018

The merged companies will provide histopathology services in the research and pre-clinical therapeutics markets.

December 12, 2018

New FDA guidance developed to identify lapses in data integrity and promote best practices.

December 11, 2018

TrendMiner 2018.R2 software for analysis of time-series data includes the ContextHub platform for expanded, self-service analytics capabilities.